natgillin/translations-raw huggingface dataset:
Table 2: Key Efficacy Outcomes for Partial Onset Seizure Frequency per 28 Days Study 
Preglednica 2: Ključni rezultati učinkovitosti za pogostnost parcialnih napadov na 28 dni Študija
- Hold the bottle upside down in one hand and use the other hand to fill the oral syringe. 
- Z eno roko držite steklenico navzdol, z drugo pa napolnite peroralno brizgo.
The European Medicines Agency has deferred the obligation to submit the results of studies with brivaracetam in one or more subsets of the paediatric population in epilepsy with partial onset seizures. 
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z brivaracetamom iz ene ali več podskupin pediatrične populacije z epilepsijo s parcialnimi napadi.
The table below only shows examples of doses to take. 
Spodnja preglednica prikazuje primere odmerkov, ki se jemljejo.
Less than 1 % of the dose is excreted in faeces and less than 10 % of brivaracetam is excreted unchanged in urine. 
Manj kot 1 % odmerka se izloči z blatom in manj kot 10 % brivaracetama se v nespremenjeni obliki izloči z urinom.
The oral solution contains sorbitol (E420). 
Peroralna raztopina vsebuje sorbitol (E420).
The lower efficacy observed in these patients compared to the leveticacetam-naïve patients was likely due to the higher number of prior AEDs used and higher baseline seizure frequency. 
Nižja učinkovitost, ki so jo opazili pri teh bolnikih v primerjavi z levetiracetam naivnimi bolniki, je bila verjetno zaradi večjega števila prej uporabljenih antiepileptikov in večje pogostnosti napadov v izhodišču.
Patients (and caregivers of patients) should be advised to seek medical advice should any signs of suicidal ideation or behaviour emerge. 
Bolnikom (in skrbnikom bolnikov) je treba svetovati, naj poiščejo zdravniško pomoč, če se pojavijo znaki samomorilnega vedenja ali razmišljanja.
Your doctor will work out the right daily dose for you. 
Zdravnik bo izračunal pravilen dnevni odmerek za vas.
How long to use Briviact for - Your doctor will decide for how many days you will be given the injections or infusion. 
Kako dolgo boste prejemali zdravilo Briviact - Vaš zdravnik bo presodil, koliko dni boste prejemali injekcije ali infuzijo.
- Then push the plunger up to remove any possible air bubbles (figure 7). 
- Nato potisnite bat navzgor, da odstranite morebitne zračne mehurčke (slika 7).
Plasma concentrations were shown to be dose-proportional in all age groups. 
Koncentracije v plazmi so bile sorazmerne z odmerkom v vseh starostnih skupinah.
No data available 
Podatki niso na voljo
It is not recommended to take Briviact if you are pregnant or breast-feeding, as the effects of Briviact on pregnancy and the unborn baby or the new-born child are not known. 
Če ste noseči ali dojite, jemanje zdravila Briviact ni priporočljivo, saj učinki zdravila Briviact na nosečnost in še nerojenega otroka ali novorojenčka niso znani.
The total plasma clearance in patients was estimated to 3.6 L/h. 
Skupni plazemski očistek pri bolnikih je bil ocenjen na 3,6 l/h.
Patients had a mean duration of epilepsy of approximately 23 years. 
Bolniki so v povprečju imeli epilepsijo 23 let.
From a microbiological point of view, the product should be used immediately after dilution. 
Z mikrobiološkega vidika je treba zdravilo uporabiti takoj po redčenju.
The number of patients with other ethnic background was limited. 
Število bolnikov drugih ras je bilo majhno.
No child received a dose greater than 200 mg/day. 
Noben otrok ni prejel odmerka, večjega kot 200 mg/dan.
The frequencies are defined as follows: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥ 1/1,000 to < 1/100). 
Pogostnosti so opredeljene takole: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100).
Stopping treatment could increase your seizures and harm your baby. 
Prekinitev zdravljenja bi lahko povečala število napadov in škodila vašemu otroku.
If you forget to take Briviact - If you miss a dose take it as soon as you remember. 
Če ste pozabili vzeti zdravilo Briviact - Če ste pozabili vzeti odmerek zdravila, ga vzemite takoj, ko se spomnite.
However, toxicological data accumulated on brivaracetam and on a structurally-related compound indicate that the dog liver changes have developed through mechanisms not relevant for humans. 
Kljub temu pa toksikološki podatki, zbrani o brivaracetamu in strukturno povezanih spojinah, kažejo, da so se spremembe v pasjih jetrih razvile z mehanizmi, ki niso relevantni za ljudi.
It is used to treat a type of epilepsy that has partial seizures with or without a secondary generalisation. 
- Uporablja se za zdravljenje vrste epilepsije s parcialnimi napadi s sekundarno generalizacijo ali brez nje.
Patients were required to have at least 8 POS during the baseline period. 
Bolniki so med izhodiščnim obdobjem morali imeti vsaj 8 parcialnih napadov.
The following table summarises the recommended posology for children from 4 years of age and adolescents. 
Naslednja preglednica vsebuje povzetek priporočenega odmerjanja za otroke od 4. leta starosti in mladostnike.
They were usually mild to moderate in intensity. 
Navadno sta bila blaga do zmerna.
Brivaracetam bolus injection or intravenous infusion has not been studied in acute conditions; e.g. status epilepticus and is therefore not recommended for such conditions. 
Injiciranja bolusa brivaracetama ali intravenske infuzije niso preučevali pri akutnih stanjih, kot je status epilepticus, zato za taka stanja ni priporočen.
Carbamazepine - None Carbamazepine-epoxide ↑ (See below) 
karbamazepin - nič karbamazepin epoksid ↑ (glejte spodaj)
Intravenous administration was associated with infusion site pain in 2.8 % of the patients. 
Intravenska uporaba je bila pri 2,8 % bolnikov povezana z bolečino na mestu infundiranja.
Brivaracetam has minor or moderate influence on the ability to drive and use machines. 
Brivaracetam ima blag ali zmeren učinek na sposobnost vožnje in upravljanja s stroji.
Adverse reactions from clinical trials 
Neželeni učinki iz kliničnih preskušanj
The EC50 (brivaracetam plasma concentration corresponding to 50 % of the maximum effect) was estimated to be 0.57 mg/L. 
EC50 (plazemska koncentracija brivaracetama, ki ustreza 50 % največjega učinka) je bila ocenjena na 0,57 mg/l.
- When you start taking this medicine you will take Briviact orally (as tablets or an oral solution) or be given it as an injection or infusion. 
- Ko boste začeli z jemanjem tega zdravila, boste zdravilo Briviact vzeli peroralno (kot tablete ali peroralno raztopino) ali pa ga boste prejeli v obliki injekcije/infuzije.
Limited data are available on neurodevelopment in children <4 years of age. 
O nevrološkem razvoju pri otrocih starih < 4 leta, so na voljo omejeni podatki.
What Briviact is and what it is used for 2. 
Kaj je zdravilo Briviact in za kaj ga uporabljamo 2.
As a precautionary measure, brivaracetam should not be used during pregnancy unless clinically necessary i.e. (if the benefit to the mother clearly outweighs the potential risk to the foetus). 
Kot varnostni ukrep se brivaracetam med nosečnostjo ne sme uporabljati, razen če to ni klinično potrebno, tj. če korist za mater jasno upravičuje potencialno tveganje za plod.
A second disposition pathway involves hydroxylation mediated by CYP2C19 (see section 5.2). 
Druga presnovna pot vključuje hidroksilacijo, posredovano s CYP2C19 (glejte poglavje 5.2).
Recommended maintenance dose 
Priporočeni vzdrževalni odmerek
(not for packsizes 14 x1 and 100 x 1 film-coated tablet) 
(ne za pakiranji po 14 x 1 in 100 x 1 filmsko obložena tableta)
Prescribers should consider adjusting the brivaracetam dose in patients starting or ending treatment with rifampicin. 
Zdravniki, ki predpisujejo zdravilo, morajo razmisliti o prilagoditvi odmerka brivaracetama pri bolnikih, ki začenjajo ali zaključujejo zdravljenje z rifampicinom.
Children and adolescents weighing less than 50 kg - Your doctor may prescribe the injection only for a few days if you cannot take your medicine by mouth. 
Otroci in mladostniki, ki tehtajo manj kot 50 kg - Zdravnik vam lahko predpiše injekcijo le za nekaj dni, če zdravila ne morete jemati peroralno
Each carton contains 10 vials. 
Ena škatla vsebuje 10 vial.
Study enrollment criteria required that patients have uncontrolled POS despite treatment with either 1 or 2 concomitant AEDs. 
Kriteriji za vključitev v študijo so zahtevali, da imajo bolniki nenadzorovane parcialne napade navkljub zdravljenju z 1 ali 2 sočasnima antiepileptikoma.
There was generally no change in the concentration-time profiles of the endogenous markers estradiol, progesterone, luteinizing hormone (LH), follicle stimulating hormone (FSH), and sex hormone binding globulin (SHBG). 
V splošnem ni bilo sprememb v profilih koncentracijačas za endogene označevalce estradiol, progesteron, luteinizirajoči hormon (LH), folikle stimulirajoči hormon (FSH), in globulin, ki se veže na spolne hormone (SHBG).
Other strong enzyme inducers (such as St John´s wort (Hypericum perforatum)) may also decrease the systemic exposure of brivaracetam. 
Tudi drugi močni induktorji encimov (npr. šentjanževka (Hypericum perforatum)) lahko zmanjšajo sistemsko izpostavljenost brivaracetama.
The precise volume of oral solution is to be calculated according to the exact body weight of the child. 
Natančna količina peroralne raztopine se izračuna s podatkom o natančni telesni masi otroka.
Each vial of Briviact solution for injection/infusion must be used only once (single use). 
Vsaka viala zdravila Briviact raztopina za injiciranje/infundiranje se lahko uporabi le enkrat (enkratna uporaba).
Children Briviact is not recommended for use in children under 4 years of age. 
Otroci Zdravila Briviact ne priporočamo za uporabo pri otrocih, mlajših od 4 let.
Brivaracetam is weakly bound (≤ 20 %) to plasma proteins. 
Brivaracetam se šibko veže (≤ 20 %) na plazemske beljakovine.
In two phase 3 randomised placebo-controlled studies, levetiracetam was administered as concomitant AED in about 20 % of the patients. 
V dveh randomiziranih študijah faze 3, nadzorovanih s placebom, je bil levetiracetam uporabljen kot sočasni antiepileptik pri približno 20 % bolnikov.
A long-term, uncontrolled, open-label safety study included children (from 4 years to less than 16 years) who continued treatment after completing the PK study (see section 5.2) and children directly enrolled into the safety study. 
V dolgoročni, nenadzorovani, odprti študiji varnosti so bili vključeni otroci (stari od 4 do manj kot 16 let), ki so po koncu farmakokinetične študije zdravljenje nadaljevali (glejte poglavje 5.2), in otroci, ki so bili vključeni neposredno v študijo varnosti.
The median tmax for tablets taken without food is 1 hour (tmax range is 0.25 to 3 h). 
Mediana čas tmax za tablete, zaužite s hrano, je 1 ura (razpon tmax je od 0,25 do 3 h).
There is insufficient data to determine the clinical significance. 
Ni dovolj podatkov, da bi določili klinični pomen tega učinka.
The safety and efficacy of brivaracetam in children aged less than 4 years have not yet been established. 
Varnost in učinkovitost brivaracetama pri otrocih, mlajših od 4 let, nista bili dokazani.
Study N01358 
Študija N01358
Since less than 10 % of brivaracetam is excreted in urine, haemodialysis is not expected to significantly enhance brivaracetam clearance (see section 5.2). 
Ker se v urin izloči manj kot 10 % brivaracetama, ne gre pričakovati, da bo hemodializa pomembno izboljšala očistek brivaracetama (glejte poglavje 5.2).
The three pivotal double-blind placebo-controlled studies included 38 elderly patients aged between 65 and 80 years. 
V treh ključnih dvojno slepih, s placebom nadzorovanih študijah je bilo udeleženih 38 starejših bolnikov, starih med 65 in 80 let.
None of the 6 cases of neutropenia were severe, required any specific treatment or led to discontinuation of brivaracetam and none had associated infections. 
Noben od teh 6 primerov nevtropenije ni bil resen, ni zahteval specifičnega zdravljenja ali povzročil prekinitve zdravljenja z brivaracetamom, poleg tega pa v povezavi z nobenim od teh primerov ni prišlo do okužb.
Patients with an improvement in percent reduction in baseline POS frequency are shown in the 4 right-most categories. 
Bolniki z izboljšanjem v odstotnem zmanjšanju osnovne pogostnosti parcialnih napadov so prikazani v 4 kategorijah na desni.
1,558 patients received study drug of which 1,099 received brivaracetam. 
Preiskovano zdravilo je prejelo 1558 bolnikov, od teh jih je 1099 prejelo brivaracetam.
The volume of distribution is 0.5 L/kg, a value close to that of the total body water. 
Volumen porazdelitve je 0,5 l/kg, kar je blizu celotni količini vode v telesu.
- If you weigh 20 kg or more, your doctor will recommend the use of the 5 ml oral syringe or the 
- Če tehtate 20 kg ali več, vam bo zdravnik svetoval, da uporabljate 5-ml peroralno brizgo ali
The maximum dose should not exceed 3 mg/kg/day. 
Največji odmerek ne sme preseči 3 mg/kg/dan.
Instructions for use are provided in the package leaflet. 
Navodila za uporabo so navedena v Navodilih za uporabo.
Intake of brivaracetam with alcohol is not recommended. 
Jemanje brivaracetama z alkoholom ni priporočljivo.
How to take Briviact tablets - Swallow the tablets whole with a glass of liquid. 
Kako jemati tablete zdravila Briviact - Tablete zaužijte cele s kozarcem tekočine.
In vivo, in human subjects possessing ineffective mutations of CYP2C19, production of the hydroxy metabolite is decreased 10-fold while brivaracetam itself is increased by 22 % or 42 % in individuals with one or both mutated alleles. 
Pri človeških preskušancih, ki so imeli neučinkovite mutacije CYP2C19, se je proizvodnja hidroksi presnovka in vivo zmanjšala za 10-krat, medtem ko se je brivaracetam povečal za 22 % oziroma 42 % pri posameznikih z mutacijo enega ali obeh alelov.
- Take the oral syringe out of the adaptor (figure 10). 
- Vzemite peroralno brizgo iz adapterja (slika 10).
- Wash the oral syringe with water only (figure 13). 
- Peroralno brizgo izperite samo z vodo (slika 13).
No additional safety or tolerability concerns were observed. 
Prav tako niso ugotovili dodatnih zadržkov glede varnosti in prenašanja.
The physician should prescribe the most appropriate formulation and strength according to weight and dose. 
Zdravnik mora predpisati najustreznejšo obliko in jakost glede na telesno maso ter odmerek.
No CYP3A4 induction was found in vivo (see midazolam above). 
In vivo indukcije CYP3A4 niso opazili (glejte midazolam zgoraj).
Experience with epilepsy medicines suggests that the results of efficacy studies performed in adults can be extrapolated to children down to the age of 4 years provided the paediatric dose adaptations are established and safety has been demonstrated (see sections 5.2 and 4.8). 
Izkušnje s protiepileptičnimi zdravili kažejo, da je mogoče rezultate študij učinkovitosti ekstrapolirati na otroke do starosti 4 let, če so bile prilagoditve na pediatrični odmerek določene in varnost dokazana (glejte poglavji 5.2 in 4.8).
Other enzyme inducers 
Drugi induktorji encimov
Figure 1: Proportion of patients by category of seizure response for brivaracetam and placebo over 12 weeks across all three double-blind pivotal trials 
Slika 1: Delež bolnikov po kategoriji odziva napadov na brivaracetam in placebo v obdobju 12 tednov v vseh treh dvojno slepih ključnih preskušanjih
When converting from oral to intravenous administration or vice versa, the total daily dose and frequency of administration should be maintained. 
Pri prehodu s peroralne na intravensko uporabo ali obratno je treba obdržati skupni dnevni odmerek in pogostnost dajanja.
Figure 1 shows the percentage of patients (excluding patients with concomitant levetiracetam) by category of reduction from baseline in POS frequency per 28 days in all 3 studies. 
Slika 1 prikazuje odstotek bolnikov (razen bolnikov, ki so sočasno prejemali levetiracetam) po kategoriji zmanjšanja glede na izhodišče in pogostnost parcialnih napadov na 28 dni v vseh 3 študijah.
Patients with rare heriditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. 
Bolniki z redko dedno intoleranco za galaktozo, laponsko obliko zmanjšane aktivnosti laktaze ali malabsorbcijo glukoze/galaktoze ne smejo jemati tega zdravila.
- Keep the bottle, the oral syringe, and the leaflet in the carton. 
- Steklenico, peroralno brizgo in navodilo shranjujte v škatli.
Carcinogenicity studies did not indicate any oncogenic potential in rats, whereas increased incidences of hepatocellular tumors in male mice are considered to result of a non-genotoxic, mode of action linked to a phenobarbitonelike liver enzyme induction, which is a known rodent specific phenomenon. 
Študije karcinogenosti na podganah niso pokazale onkogenega potenciala, medtem ko je bila povečana incidenca tumorjev jetrnih celic pri mišjih samcih smatrana kot rezultat negenotoksičnega mehanizma delovanja, povezanega z induciranjem jetrnih encimov, podobnega kot pri fenobarbitonu, kar je znan specifičen pojav za glodavce.
- Pull the plunger down to the millilitre (ml) dose marker on the oral syringe prescribed by your doctor (figure 8). 
- Izvlecite bat navdol do oznake mililitrskega (ml) odmerka na peroralni brizgi, ki vam ga je predpisal vaš zdravnik,(slika 8).
Brivaracetam is rapidly and completely absorbed after oral administration and the absolute bioavailablity is approximately 100 %. 
Brivaracetam se hitro in v celoti absorbira po peroralni uporabi, absolutna biološka razpoložljivost pa je približno 100 %.
- If you weigh less than 20 kg, you should use the 5 ml oral syringe provided in the carton to ensure accurate dosing. 
- Če tehtate manj kot 20 kg, morate uporabljati 5-ml peroralno brizgo, priloženo v škatli, da zagotovite natančno odmerjanje.
Common: may affect up to 1 in 10 people - restlessness and hyperactivity (psychomotor hyperactivity) 
Pogosti: pojavijo se lahko pri največ 1 od 10 bolnikov - nemir in hiperaktivnost (psihomotorična hiperaktivnost)
50% Responder rate 
50 % delež odzivnosti
In a pharmacokinetic study with a 3-week evaluation period and weekly fixed 3-step up-titration using the brivaracetam oral solution, 99 subjects aged 1 month to <16 years were evaluated. 
V farmakokinetični študiji s 3-tedenskim obdobjem ocenjevanja in tedenskim določenim titriranjem v 3 korakih s peroralno raztopino brivaracetama, je bilo ocenjenih 99 preskušancev, starih od 1 meseca do < 16 let.
All packs are available in PVC/PCTFE - Aluminium blisters. 
Vsa pakiranja so na voljo v pretisnih omotih PVC/PCTFE-aluminij.
This is because stopping treatment could increase the number of fits you have. 
To je pomembno zato, ker bi lahko prekinitev zdravljenja povečala število epileptičnih napadov, ki jih doživljate.
If brivaracetam has to be discontinued it is recommended to withdraw it gradually by 50 mg/day on a weekly basis. 
Če je treba prekiniti jemanje brivaracetama, je priporočeno postopno zmanjševanje odmerka po 50 mg/dan na teden.
In children aged 4 years and older, partial onset seizures have a similar clinical expression to those in adolescents and adults. 
Pri otrocih, starih 4 leta in več, se parcialni epileptični napadi klinično izražajo podobno kot pri mladoletnikih in odraslih.
- Pull the plunger down to fill the oral syringe with a small amount of solution (figure 6). 
- Izvlecite bat navzdol, da napolnite peroralno brizgo z majhno količino raztopine (slika 6).
This plasma concentration is slightly above the median exposure obtained after brivaracetam doses of 50 mg/day. 
Ta plazemska koncentracija je rahlo nad mediano izpostavljenosti, ki je bila dosežena pri odmerkih brivaracetama 50 mg/dan.
In a pharmacokinetic and pharmacodynamic interaction study between brivaracetam 200 mg single dose and ethanol 0.6 g/L continuous infusion in healthy subjects, there was no pharmacokinetic interaction but brivaracetam approximately doubled the effect of alcohol on psychomotor function, attention and memory. 
V študiji farmakokinetičnih in farmakodinamičnih interakcij med enkratnim odmerkom brivaracetama 200 mg in neprekinjeno infuzijo etanola 0,6 g/l pri zdravih preskušancih ni bilo farmakokinetičnih interakcij, vendar je brivaracetam približno podvojil učinek alkohola na psihomotorične funkcije, pozornost in spomin.
A small number of people being treated with anti-epileptic medicines such as Briviact have had thoughts of harming or killing themselves. 
Pri majhnem številu bolnikov, ki so se zdravili z antiepileptiki, kot je zdravilo Briviact, so se pojavile misli o samopoškodovanju ali samomoru.
There was no additive effect of brivaracetam and valproate on the AUC of carbamazepine epoxide. 
Aditivnega učinka brivaracetama in valproata na AUC karbamazepin epoksida ni bilo.
Brivaracetam is a moderate reversible inhibitor of epoxide hydrolase resulting in an increased concentration of carbamazepine epoxide, an active metabolite of carbamazepine. 
Brivaracetam je zmeren reverzibilni zaviralec epoksid-hidrolaze, kar povzroči povečano koncentracijo karbamazepin epoksida, aktivnega presnovka karbamazepina.
There is no experience with twice daily intravenous administration of brivaracetam for a period longer than 4 days. 
Izkušenj z intravenskim odmerjanjem brivaracetama dvakrat na dan za obdobje, daljše kot 4 dni, ni.
Effects of other agents on the pharmacokinetics of brivaracetam In vitro data suggest that brivaracetam has a low interaction potential. 
Učinki drugih zdravilnih učinkovin na farmakokinetiko brivaracetama Podatki in vitro kažejo, da ima brivaracetam nizek interakcijski potencial.
Component of a multipack, can't be sold separately. 
Sestavni del večkratnega pakiranja, ni za ločeno prodajo.
In vitro, interaction studies to determine the potential inhibitory effects on transporters concluded that there were no clinically relevant effects, except for OAT3. 
In vitro študije interakcij, kjer so ugotavljali potencialne zaviralne učinke na prenašalce so pokazale, da ni klinično pomembnih učinkov, razen na OAT3.
Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A), a transmembrane glycoprotein found at presynaptic level in neurons and in endocrine cells. 
Brivaracetam kaže visoko in selektivno afiniteto do proteina sinaptičnega vezikla 2A (SV2A), transmembranskega glikoproteina, ki je prisoten na predsinaptični ravni v nevronih in endokrinih celicah.
Brivaracetam solution for injection/infusion is physically compatible and chemically stable when mixed with the following diluents 
Raztopina brivaracetama za injiciranje/infundiranje je fizikalno kompatibilna in kemijsko stabilna, če jo zmešate z naslednjimi raztopinami.
Brivaracetam was evaluated in these patients in a short term openlabel pharmacokinetic study and an ongoing open-label extension study, in 16 subjects from 1 month to <4 years of age (see section 5.2). 
Brivaracetam so pri teh bolnikih ocenjevali v kratkotrajni odprti študiji farmakokinetike in v odprti podaljšani študiji v teku pri 16 preskušancih, starih od 1 meseca do < 4 leta (glejte poglavje 5.2).
There are two ways in which you can choose to drink the medicine: - empty the contents of the syringe into water (or juice) by pushing the plunger to the bottom of the oral syringe (figure 11) - you will then need to drink all of the water (add just enough to make it easy to drink) or - drink the solution directly from the oral syringe without water - drink the whole contents of the syringe (figure 12). 
Zdravilo lahko vzamete na dva načina: - vsebino brizge izpraznite v vodo (ali sok) tako, da pritisnete na bat na dnu peroralne brizge (slika 11) - nato spijte vso vodo (vode naj bo ravno dovolj, da boste lahko vse enostavno spili) ali
If you have more Briviact than you should If you think you have been given too much Briviact, tell your doctor straight away. 
Če ste prejeli večji odmerek zdravila Briviact, kot bi smeli Če mislite, da ste prejeli preveč zdravila Briviact, takoj obvestite zdravnika.
There is a limited amount of data from the use of brivaracetam in pregnant women. 
O uporabi brivaracetama pri nosečnicah je na voljo omejena količina podatkov.